糖皮質(zhì)激素受體(GR)活性蛋白
Active Glucocorticoid Receptor (GR)
GCCR; GCR; NR3C1; GRL; NR3-C1; Nuclear Receptor Subfamily 3, Group C, Member 1
- 編號(hào)APB608Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)6.2
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1531 ¥ 3828 ¥ 7656 ¥ 22968 ¥ 57420
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
活性實(shí)驗(yàn)
Glucocorticoid Receptor (GR) is a member of the steroid receptor superfamily, which includes receptors for other steroid hormones such as estrogens, progestogens, androgens and mineralocorticoids. GR is widely distributed in various types of human cells, especially in liver, muscle, adipose tissue, lung, brain and other organs. GR plays a role in signaling within cells. When glucocorticoids enter cells and bind to GR, GR undergoes conformational changes that activate its transcriptional activity. It has been identified that the binding of Heat Shock 70kDa Protein 4 (HSPA4) to GR plays a key role in glucocorticoid signaling, which not only participates in the stabilization and activation of receptors, but also may affect the effect of drugs. Thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human GR and recombinant human HSPA4. Briefly, GR was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to HSPA4-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-GR pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450/630 nm immediately. The binding activity of recombinant human GR and recombinant human HSPA4 was shown in Figure 1, the EC50?for this effect is 5.1 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB608Hu06 | 糖皮質(zhì)激素受體(GR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB608Hu01 | 糖皮質(zhì)激素受體(GR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB608Hu02 | 糖皮質(zhì)激素受體(GR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB608Hu04 | 糖皮質(zhì)激素受體(GR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB608Hu03 | 糖皮質(zhì)激素受體(GR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB608Hu01 | 糖皮質(zhì)激素受體(GR)活性蛋白 | Cell?culture;?Activity?Assays. |
PAB608Hu03 | 糖皮質(zhì)激素受體(GR)多克隆抗體 | WB; IHC; ICC; IP. |
PAB608Hu01 | 糖皮質(zhì)激素受體(GR)多克隆抗體 | WB; IHC; ICC; IP. |
PAB608Hu02 | 糖皮質(zhì)激素受體(GR)多克隆抗體 | WB,IHC |
LAB608Hu71 | 糖皮質(zhì)激素受體(GR)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAB608Hu22 | 糖皮質(zhì)激素受體(GR)單克隆抗體 | WB; IHC; ICC; IP. |
MAB608Hu21 | 糖皮質(zhì)激素受體(GR)單克隆抗體 | WB; IHC; ICC; IP. |
SEB608Hu | 糖皮質(zhì)激素受體(GR)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB608Hu | 糖皮質(zhì)激素受體(GR)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Frontiers in Neuroscience | Endoplasmic Reticulum Stress PERK-ATF4-CHOP Pathway Is Associated with Hypothalamic Neuronal Injury in Different Durations of Stress in Rats [pubmed:28392758] |